February 16th, 2015, 7:56 pm
Paper by Albanese and Andersen - "Accounting for OTC Derivatives: Funding Adjustments and the Re-Hypothecation Option"Any thoughts, in particular on their statement that fair value should not include a funding adjustment? Also, the statement that the current "FCA/FBA" method of accounting for funding cost should be replaced by their proposed "FVA/FDA" method?Thanks.